ArticleBiotech (Basel (Switzerland))2026
Sustainable Curcumin-Loaded Poly(Glyceryl Adipate) Nanoparticles Attenuate Adjuvant-Induced Arthritis: A Comprehensive Study from Synthesis to Gene Expression Analysis.
Article in Biotech (Basel (Switzerland)), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Curcumin can behave potently as an anti-inflammatory agent, but unfortunately, it suffers from a detrimental aqueous solubility and a limited bioavailability, which hinders its usage in clinical applications. Formulating a polymeric nanosized biocompatible system can increase the delivered curcumin fraction intra-articularly for inflammatory diseases. Poly(glyceryl adipate) nanoparticles were synthesized using a polycondensation process yielding six different polymers, which was followed by a preparation of different curcumin-loaded formulations using the nanoprecipitation method. The selected formulation exhibited a particle size of 115.8 ± 10.9 nm, a mean PDI of 0.191 ± 0.038, a zeta potential of -22.9 ± 1.5 mV, and an EE of about 95%. This formulation was subjected to physicochemical characterization, including TEM, FTIR, DSC, and an in vitro release study. The stability was assessed in the presence of sodium sulfate at different concentrations, and the long-term stability was assessed through three months of storage. The cytocompatibility was evaluated by an MTT assay on normal and cancerous cell lines, revealing no significant cytotoxicity, and RT-qPCR was done in order to point out the anti-inflammation effect of the produced nanoparticles. Finally, a molecular docking study was held against Bruton's tyrosine kinase. The formulation's findings demonstrate the potential of nanoparticles, providing a basis for further in vivo studies targeting arthritis therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.